Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
21.83
-0.46 (-2.06%)
At close: Mar 24, 2026, 4:00 PM EDT
22.00
+0.17 (0.78%)
After-hours: Mar 24, 2026, 7:41 PM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $2.71 billion as of March 24, 2026. Its market cap has increased by 58.71% in one year.
Market Cap
2.71B
Enterprise Value
2.60B
1-Year Change
58.71%
Ranking
Category
Stock Price
$21.83
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $2.71B, an increase of 246.23%. That is a compound annual growth rate of 22.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 2.71B | -23.88% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 2.96B |
| Dyne Therapeutics | 2.90B |
| Vera Therapeutics | 2.89B |
| IDEAYA Biosciences | 2.88B |
| Catalyst Pharmaceuticals | 2.78B |
| Tango Therapeutics | 2.77B |
| Viridian Therapeutics | 2.76B |
| Tarsus Pharmaceuticals | 2.75B |